Insights into the regulatory control of INHA expression could shed further light on the role of INHA in human adrenal tumorigenesis and on the variability of serum free circulating inhibin levels that could function as serum tumor marker in ACC patients. The gene discussed is INHA; the disease is adrenal cortex carcinoma.